No Data
No Data
No Data
No Data
No Data
Memphasys Ltd Gains Momentum in Global Markets
TipRanksApr 29 03:17 ET
Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9%
Memphasys (ASX:MEM) secured an order for its Felix fertility device system with Vitrolife Japan, a subsidiary of Swedish medical distributor Vitrolife Group, according to a filing with the Australian
MT NewswiresMar 17 21:38 ET
Memphasys Completes Trial of Animal Fertility System
Memphasys (ASX:MEM) completed a field trial of its artificial insemination port system consisting of four bulls and 146 cows at a stud farm in New South Wales. The system was able to reach 60% of the
MT NewswiresJan 26 00:34 ET
Memphasys' Entitlement Offer Undersubscribed
Memphasys' (ASX:MEM) non-renounceable entitlement offer incurred a shortfall of 158.9 million rights, the reproductive biotechnology firm said on Friday. Of the 213.2 million rights offered, only 54.3
MT NewswiresJan 11 23:32 ET
Memphasys Accelerates Commercial Approval for Sperm-separation Device
Despite innovative technology, Memphasys (ASX:MEM) has been swimming against the tide in recent times. But with the company poised to bank $4.23 million in a capital raising and having signed expanded
sharecafeJan 10 01:03 ET
Memphasys Signs Distribution Deals for Fertility System; Shares Jump 8%
Memphasys (ASX:MEM) signed a deal with subsidiaries of Swedish in vitro fertilization firm Vitrolife to distribute the Felix reproductive system in the markets of Canada and New Zealand. First orders
MT NewswiresJan 1 21:51 ET
No Data
No Data